Content Type: Policy Interactions

Comments on Draft Guidance, “Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics”

March 17, 2026

Comments on Notice, “New Drugs Regulatory Program Modernization: Improving Approval Package Documentation and Communication” (Herder et al.)

March 17, 2026

Comments on Proposed Rule, “Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products”

March 17, 2026

Comments on Draft Guidance, “Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules”

March 17, 2026